Circulating microRNAs as diagnostic biomarkers for pancreatic cancer

References

• Vincent A, Herman J, Schulick R, et al. Pancreatic cancer. The Lancet. 2011;378(9791):607–620.
   PubMed Web of Science ®Google Scholar
• Rahib L, Smith BD, Aizenberg R, et al. Projecting Cancer Incidence and Deaths to 2030: the Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States. Cancer Res. 2014;74(11):2913–2921.
   PubMed Web of Science ®Google Scholar
• Bledsoe JR, Shinagare SA, Deshpande V. Difficult Diagnostic Problems in Pancreatobiliary Neoplasia. Arch Pathol Lab Med. 2015;139(7):848–857.
   PubMed Web of Science ®Google Scholar
• Ballehaninna UK, Chamberlain RS. Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9. Tumour Biol: J Int Soc Oncodevel Biol Med. 2013;34(6):3279–3292.
   PubMed Web of Science ®Google Scholar
• Rachagani S, Macha MA, Heimann N, et al. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Adv Drug Deliv Rev. 2015;81:16–33.
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259–269.
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997–1006.
   PubMed Web of Science ®Google Scholar
• Li A, Yu J, Wolfgang CL, et al. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res. 2013;19(13):3600–3610.
   Web of Science ®Google Scholar
• Schultz NA, Dehlendorff C, Jensen BV, et al. MIcrorna biomarkers in whole blood for detection of pancreatic cancer. JAMA: J Am Med Assoc. 2014;311(4):392–404.
   PubMed Web of Science ®Google Scholar
• Xu J, Cao Z, Liu W, et al. Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: a Multicenter Study. Ann Surg 2015. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Frampton AE, Krell J, Jamieson NB, et al. microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis. Eur J Cancer. 2015;51(11):1389–1404.
   PubMed Web of Science ®Google Scholar
• Frampton AE, Giovannetti E, Jamieson NB, et al. A microRNA meta-signature for pancreatic ductal adenocarcinoma. Expert Rev Mol Diagn. 2014;14(3):267–271.
   PubMed Web of Science ®Google Scholar
• Frampton AE, Castellano L, Colombo T, et al. MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression. Gastroenterology. 2014;146(1):268–277 e218.
   PubMed Web of Science ®Google Scholar
• Liu J, Gao J, Du Y, et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer. 2012;131(3):683–691.
   PubMed Web of Science ®Google Scholar
• Wang WS, Liu LX, Gp L, et al. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Cancer Prev Res (Phila). 2013;6(4):331–338.
   PubMed Web of Science ®Google Scholar
• Frampton AE, Fletcher CE, Gall TM, et al. Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer. Expert Rev Mol Diagn. 2013;13(5):425–430.
   PubMed Web of Science ®Google Scholar
• Churchill GA. Fundamentals of experimental design for cDNA microarrays. Nat Genet. 2002;32(Suppl):490–495.
   PubMed Web of Science ®Google Scholar
• Peng X, Wood CL, Blalock EM, et al. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics. 2003;4:26.
   PubMed Web of Science ®Google Scholar
• Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila). 2012;5(3):492–497.
   PubMed Web of Science ®Google Scholar
• Sourvinou IS, Markou A, Lianidou ES. Quantification of Circulating miRNAs in Plasma: effect of Preanalytical and Analytical Parameters on Their Isolation and Stability. J Mol Diagn. 2013;15(6):827–834.
   PubMed Web of Science ®Google Scholar
• Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010;127(1):118–126.
   PubMed Web of Science ®Google Scholar
• Kroh EM, Parkin RK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010;50(4):298–301.
   PubMed Web of Science ®Google Scholar
• Zhu C, Ren C, Han J, et al. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br J Cancer. 2014;110(9):2291–2299.
   PubMed Web of Science ®Google Scholar
• Jia W, Wu Y, Zhang Q, et al. Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring. Mol Clin Oncol. 2015;3(4):851–858.
   PubMedGoogle Scholar
• Shen J, Todd NW, Zhang H, et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest. 2011;91(4):579–587.
   PubMed Web of Science ®Google Scholar
• Hunten S, Kaller M, Drepper F, et al. p53-regulated networks of protein, mRNA, miRNA and lncRNA expression revealed by integrated pSILAC and NGS analyses. Mol Cell Proteomics. 2015;14(10):2609–2629.
   PubMed Web of Science ®Google Scholar
• Song L, Lin C, Gong H, et al. miR-486 sustains NF-kappaB activity by disrupting multiple NF-kappaB-negative feedback loops. Cell Res. 2013;23(2):274–289.
   PubMed Web of Science ®Google Scholar
• Beatty GL, Chiorean EG, Fishman MP, et al. CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans. Science. 2011;331(6024):1612–1616.
   PubMed Web of Science ®Google Scholar
• Yan W, Liu Y, Yang P, et al. MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype. Oncotarget. 2015;6(13):11676–11682.
   PubMedGoogle Scholar
• Butz H, Liko I, Czirjak S, et al. MicroRNA profile indicates downregulation of the TGFbeta pathway in sporadic non-functioning pituitary adenomas. Pituitary. 2011;14(2):112–124.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Park S-Y, Su J, et al. TCF7L2 is a master regulator of insulin production and processing. Hum Mol Genet. 2014;23(24):6419–6431.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao G, Yang C, et al. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci. 2014;15(6):10567–10577.
   PubMed Web of Science ®Google Scholar
• Hamilton MP, Rajapakshe K, Hartig SM, et al. Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif. Nat Commun. 2013;4:2730.
   PubMed Web of Science ®Google Scholar
• D’Souza-Schorey C, Clancy JW. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 2012;26(12):1287–1299.
   PubMed Web of Science ®Google Scholar